RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

NYSE Euronext, Inc.

A collection of news and information related to NYSE Euronext, Inc. published by this site and its partners.

Top NYSE Euronext, Inc. Articles

Displaying items 73-84
  • BofA reports first quarterly loss since 2011 on lofty legal bill

    (Reuters) - Bank of America Corp reported an unexpected first-quarter loss on Wednesday after it took a $6 billion charge to cover litigation expenses, a figure that far exceeded the legal settlements the No. 2 U.S. bank has announced recently. Revenue...
  • Abbott Laboratories profit beats forecast, but sales lag

    (Reuters) - Abbott Laboratories Inc reported better-than-expected quarterly earnings on Wednesday, but combined sales of its nutritional products, medical devices and generic medicines were slightly below Wall Street expectations. The company earned $375...
  • BlackRock's quarterly profit climbs as investors pile into funds

    NEW YORK (Reuters) - BlackRock Inc, the world's largest money manager, said on Thursday first-quarter profit rose 20 percent, boosted by strong performance fees and strength in its retail business as investors poured money into long-term funds. The New...
  • NBA? Kevin Ollie Tells Gayle King, 'Not Now ... But Never Say Never'

    NBA? Kevin Ollie Tells Gayle King, 'Not Now ... But Never Say Never'
    Kevin Ollie was interviewed on CBS This Morning Wednesday by Gayle King. He covered a lot of territory he has already covered recently, but he did address the prospects of coaching in the NBA, appearing to close the door on it now, but not in the future....
  • FDA OKs new generation Boston Scientific heart pacing devices

    (Reuters) - U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday. The Food and Drug...
  • J&J beats forecasts as sales of new drugs shine

    (Reuters) - Johnson & Johnson reported quarterly earnings well above expectations, as strong sales of new drugs offset weak demand for consumer products and medical devices, and the company slightly raised its full-year profit view. J&J on Tuesday said...
  • Zebra Tech to buy Motorola Solutions' enterprise business

    (Reuters) - Barcode printer maker Zebra Technologies Corp said it would buy Motorola Solutions Inc's enterprise business, which makes rugged mobile computers, tablets and barcode scanners, for $3.45 billion in its biggest deal ever. The deal will allow...
  • ECB prepared to ease if inflation low for too long: Noyer

    NEW YORK (Reuters) - The European Central Bank stands ready to take unconventional policy steps to fend off a "too prolonged" period of low inflation, though for now it expects inflation to rebound slowly, an ECB policymaker said on Monday. "Should we...
  • Merck's grass pollen allergy drug wins U.S. approval

    (Reuters) - Merck & Co said the U.S. Food and Drug Administration on Monday approved its grass pollen allergy drug Grastek, becoming the second such immunotherapy treatment to be given the go-ahead in recent weeks. The company, which developed the tablet...
  • Edwards shares up on injunction against Medtronic heart valve

    (Reuters) - Shares of Edwards Lifesciences Corp jumped 13 percent on Monday after a U.S. court temporarily halted sales of competitor Medtronic Inc's heart valve implant that uses a less-invasive procedure to spare patients from open-heart surgery. The...
  • Walgreen under shareholder pressure to relocate to Europe: FT

    (Reuters) - U.S. drugstore chain operator Walgreen Co is under pressure from a group of shareholders to consider relocating to Europe to gain tax benefits, the Financial Times reported. Shareholders owning nearly 5 percent of the company's shares lobbied...
  • Twitter CEO, co-founders not to sell shares after lockup ends

    Twitter CEO, co-founders not to sell shares after lockup ends
    (Reuters) - Twitter Inc co-founders, Jack Dorsey and Evan Williams, and Chief Executive Richard Costolo have informed U.S. regulators that they did not plan to sell the microblogging company's shares after post-IPO restrictions are lifted in May....